A detailed history of Barclays PLC transactions in Haemonetics Corp stock. As of the latest transaction made, Barclays PLC holds 102,533 shares of HAE stock, worth $7.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
102,533
Previous 102,533 -0.0%
Holding current value
$7.74 Million
Previous $8.24 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$72.45 - $91.58 $4.89 Million - $6.18 Million
67,470 Added 192.43%
102,533 $8.24 Million
Q2 2024

Aug 14, 2024

SELL
$81.24 - $97.37 $5.59 Million - $6.7 Million
-68,802 Reduced 66.24%
35,063 $2.9 Million
Q1 2024

May 15, 2024

SELL
$71.24 - $85.35 $1.07 Million - $1.28 Million
-15,034 Reduced 12.64%
103,865 $8.87 Million
Q4 2023

Feb 15, 2024

BUY
$80.59 - $92.61 $6.55 Million - $7.53 Million
81,303 Added 216.25%
118,899 $10.2 Million
Q3 2023

Nov 07, 2023

SELL
$82.56 - $93.49 $500,231 - $566,455
-6,059 Reduced 13.88%
37,596 $3.37 Million
Q2 2023

Aug 03, 2023

BUY
$80.84 - $89.45 $453,189 - $501,456
5,606 Added 14.73%
43,655 $3.72 Million
Q1 2023

May 04, 2023

BUY
$72.75 - $90.6 $1.13 Million - $1.41 Million
15,572 Added 69.28%
38,049 $3.15 Million
Q4 2022

Feb 13, 2023

BUY
$73.85 - $86.14 $1.21 Million - $1.42 Million
16,427 Added 271.52%
22,477 $1.77 Million
Q3 2022

Nov 03, 2022

BUY
$63.3 - $78.66 $102,166 - $126,957
1,614 Added 36.38%
6,050 $447,000
Q2 2022

Aug 12, 2022

SELL
$49.27 - $66.08 $385,389 - $516,877
-7,822 Reduced 63.81%
4,436 $289,000
Q1 2022

May 16, 2022

SELL
$43.77 - $63.22 $2.72 Million - $3.93 Million
-62,235 Reduced 83.54%
12,258 $776,000
Q4 2021

Feb 14, 2022

BUY
$49.55 - $74.59 $856,868 - $1.29 Million
17,293 Added 30.23%
74,493 $3.95 Million
Q3 2021

Nov 09, 2021

BUY
$57.6 - $70.59 $1.1 Million - $1.35 Million
19,084 Added 50.07%
57,200 $4.04 Million
Q2 2021

Aug 13, 2021

BUY
$51.81 - $118.56 $658,867 - $1.51 Million
12,717 Added 50.07%
38,116 $2.54 Million
Q1 2021

May 13, 2021

BUY
$111.01 - $139.48 $2.66 Million - $3.35 Million
23,993 Added 1706.47%
25,399 $2.82 Million
Q4 2020

Feb 11, 2021

SELL
$88.75 - $119.95 $34,168 - $46,180
-385 Reduced 21.5%
1,406 $167,000
Q3 2020

Nov 12, 2020

SELL
$75.65 - $93.58 $1.23 Million - $1.52 Million
-16,239 Reduced 90.07%
1,791 $157,000
Q2 2020

Aug 12, 2020

SELL
$84.96 - $118.91 $113,421 - $158,744
-1,335 Reduced 6.89%
18,030 $1.61 Million
Q1 2020

May 13, 2020

SELL
$74.34 - $121.82 $2.98 Million - $4.88 Million
-40,045 Reduced 67.4%
19,365 $1.93 Million
Q4 2019

Feb 10, 2020

BUY
$114.37 - $129.46 $2.73 Million - $3.09 Million
23,880 Added 67.21%
59,410 $6.83 Million
Q3 2019

Nov 14, 2019

SELL
$117.16 - $138.52 $613,684 - $725,567
-5,238 Reduced 12.85%
35,530 $4.48 Million
Q2 2019

Aug 14, 2019

SELL
$81.74 - $120.34 $384,341 - $565,838
-4,702 Reduced 10.34%
40,768 $4.91 Million
Q1 2019

May 15, 2019

BUY
$83.25 - $102.12 $2.62 Million - $3.21 Million
31,421 Added 223.65%
45,470 $3.98 Million
Q4 2018

Feb 14, 2019

SELL
$90.66 - $116.63 $2.54 Million - $3.27 Million
-28,064 Reduced 66.64%
14,049 $1.41 Million
Q3 2018

Nov 14, 2018

SELL
$89.96 - $114.58 $315,309 - $401,602
-3,505 Reduced 7.68%
42,113 $4.83 Million
Q2 2018

Aug 14, 2018

BUY
$71.53 - $95.75 $2.04 Million - $2.72 Million
28,453 Added 165.76%
45,618 $4.09 Million
Q1 2018

May 15, 2018

BUY
$60.72 - $74.41 $347,864 - $426,294
5,729 Added 50.1%
17,165 $1.26 Million
Q4 2017

Feb 14, 2018

BUY
$44.96 - $58.99 $372,898 - $489,263
8,294 Added 263.97%
11,436 $664,000
Q3 2017

Nov 14, 2017

BUY
$40.38 - $44.87 $126,873 - $140,981
3,142
3,142 $141,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.87B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.